- Original article
- Open access
- Published:
Role of fiberoptic bronchoscopy in the diagnosis of pulmonary infiltrates in patients with hematological malignancies
Egyptian Journal of Bronchology volume 12, pages 340–345 (2018)
Abstract
Rationale
Patients with hematological malignancies are a special challenge to health care providers as they undergo a wide variety of immune-suppressive therapies. Both disease and therapy can cause complications. The lungs may be directly injured through infectious or toxic insults. Early identification of the nature of infiltrates will result in better outcome in the management of these patients. Fiberoptic bronchoscopy (FOB) may be a good tool for indentifying the infiltrate nature by using different diagnostic techniques like transbronchial lung biopsy (TBLB) and bronchoalveolar lavage (BAL).
Patients and methods
This study was performed over 6 months, in Kasr Al-Aini Hospital, Cairo University. It included 30 patients with hematological malignancies presenting with pulmonary infiltrates confirmed by computed tomography of the chest. All patients underwent history taking, clinical examination, and investigations included complete blood count and coagulation profile, BAL for culture and sensitivity, cytology examination, and TBLB.
Results
Overall diagnostic yield of FOB was 73.3% in this study. The diagnostic yield of FOB was higher for infectious (43.3%) than both noninfectious (20%) and mixed (10%) etiologies. The combined diagnostic yield of BAL for bacteriological examination and TBLB was higher than that of BAL for cytology examination. Bacteriological examination revealed a predominance for gram-negative bacteria in 62.5% of total culture and sensitivity.
Conclusion
This study supports the role of FOB as the initial procedure of choice for identifying the nature of pulmonary infiltrates in patients with hematological malignancies. Because our results suggest that BAL and TBLB are complementary, we recommend performing TBLB whenever it is deemed safe. On the contrary, cytological examination of BAL fluids was not helpful in reaching a final diagnosis.
References
Jones RJ, Armstrong SA. Cancer stem cells in hematopoietic malignancies. Biol Blood Marrow Transplant 2008;14:12–16.
Nelson MH, Paulos CM. Novel immunotherapies for hematologic malignancies. Immunol Rev 2015;263:90–105.
Shorr A, Kollef M. The quick and the dead:the importance of rapid evaluation of infiltrates in the immunocompromised patient. Chest 2002;122:9–12.
Azoulay É, Ayman OS. Respiratory infections in patients with hematological malignancies:pulmonary involvement in patients with haematological malignancies. Berlin Heidelberg:Springer-Verlag 2011; 10:9–38.
Bommart S, Bourdin A, Makinson A, Durand G, Micheau A, Monnin-Bares V, et al. Infectious chest complications in haematological malignancies. Diagn Interv Imaging 2013;94:199–207.
Choi MH, Jung JI, Chung WD, Kim YJ, Lee SE, Han DH, et al. Acute pulmonary complications in patients with hematologic malignancies. Radiographics 2014;34:1755–1768.
Shawgi S, Kumar L, Kochupillai V, Shukla NK, Broor S, Kapila K, et al. Evaluation of pulmonary infiltrates in patients with haematological malignancies using fibreoptic bronchoscopy and bronchoalveolar lavage. Indian J Med Paediatr Oncol 2004;25:10–21.
Murro D, Slade JM, Gattuso P. Cytologic findings of hematologic malignancies in bronchoalveolar lavage fluid. J Am Soc Cytopathol 2015;4:267–275.
Cazzadori A, Di Perri G, Todeschini G, Luzzati R, Boschiero L, Perona G, et al. Transbronchial biopsy in the diagnosis ofpulmonary infiltrates in immunocompromised patients. Chest 1995;107:101–106.
Curley FJ, Johal JS, Burke ME, Fraire AE. Transbronchial lung biopsy:can specimen quality be predicted at the time of biopsy? Chest 1998;113:1037–1041.
American Cancer Society. Cancer facts and figures 2014. Available at:http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-041770.pdf. [Last accessed 2017 Oct 1].
The Most Frequent Cancers, All Aswan Governorate, Egypt, 2008. Available at:http://www.cancerregistry.gov.eg. [Last accessed 2017 Oct 1].
Ibrahim AS, Khaled HM, Mikhail NNH, Baraka H, Kamel H. Cancer incidence in Egypt:results of the national population-based cancer registry program. J Cancer Epidemiol 2014; 2014:437971.
Shirley MH, Sayeed S, Bames I, Finlayson A, Ali R. Incidence of hemtological malignancies by ethic group in England. Br J Hematol 2013;163:465–477.
Ahmed S, Siddiqui AK. Pulmonary complications in chronic lymphocytic leukemia. Cancer 2003;98:1912–1917.
Smith A, Crouch S, Lax S, Li J, Painter D, Howell D, et al. Lymphoma incidence, survival, and prevalence 2004-2014:sub-type analyses from the UK’s:hematological malignancy research network. Br J Cancer 2015;112:1575–1584.
Parikh SA, Rabe KG, Kay NE, Call TG, Ding W, Schwager S, et al. Chronic lymphocytic leukemia in young <55 years patient:a comprehensive analysis of prognostic factors and outcomes. Hematologica 2013;99:140–147.
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics. CA Cancer J Clin 2014;64:83–103.
Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 2004;125:712–722.
Tanaka N, Matsumoto T, Miura G, Emoto T, Matsunaga N. HRCT findings of chest complications in patients with leukemia. Eur Radiol 2002;12:1512–1522.
Hofmeister CC, Czerlanis C, Forsythe S, Stiff PJ. Retrospective utility of bronchoscopy after hematopoietic stem cell transplant. Bone Marrow Transplant 2006;38:693–698.
Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant 2007;40:63–70.
Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004;170:22–48.
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice for the use of antimicrobial agents in neutropenic patients with cancer:update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:e56–e93.
Tertemiz KC, OzgenAlpaydin A, Salman S, Alacacioglu I. Diagnostic yield of bronchoalveolar lavage in hematological malignancies. Eur Respir J 2015; 46:2646.
Drent M, Wagenaar SS, Mulder PH, van Velzen-Blad H, Diamant M, van den Bosch JM. Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis and non-Hodgkin’s and Hodgkin’s disease. An evaluation of differences. Chest 1994;105:514–519.
Zompi S, Couderc LJ, Cadranel J. Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood 2004;103:3208–3218.
Poletti V, Romagna M, Gasponi A, Baruzzi G, Allen KA. Bronchoalveolar lavage in the diagnosis of low-grade, MALT type, B-cell lymphoma of the lung. Monaldi Arch Chest Dis 1995;50:191–194.
Poletti V, Salvucci M, Zanchini R. The lung as a target organ in patients with hematologic disorders. Haematologica 2000;85:855–864.
Semenzato G, Poletti V. Bronchoalveolar lavage in lung cancer. Respiration 1992;59:44–46.
Azoulay E, Fieux F, Moreau D, Thiery G, Rousselot P, Parrot A. Acute monocytic leukaemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003;167:1329–1333.
Poletti V, Poletti G, Murer B. Bronchoalveolar lavage in malignancy. Semin Respir Crit Care Med 2007;28:534–545.
Rennard SI, Ghafouri M, Thompson AB, Linder J, Vaughan W, Jones K, et al. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis 1990;141:208–217.
Klech H, Hutter C. Clinical guidelines and indications for bronchoalveolar lavage (BAL):report of the European Society of Pneumology Task Group on BAL. Eur Respir J 1990;3:937–969.
Mulabecirovic A, Gaulhofer P, Auner HW, Popper H, Krause R, Hesse C, et al. Pulmonary infiltrates in patients with haematologic malignancies:transbronchial lung biopsy increases the diagnostic yield with respect to neoplastic infiltrates and toxic pneumonitis. AnnHematol 2004;83:420–422.
Hohenadel I, Kiworr M, Genitsariotis R, Zeidler D, Lorenz J. Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen. Thorax 2001;56:115–120.
Rano A, Agusti C, Jimenez P, Angrill J, Benito N, Daned C, et al. Pulmonary infiltrates in non-HIV immunocompromised patients:a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001;56:379–387.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Akl, Y.M.K., Zawam, H.M.E., ElKorashy, R.I.M. et al. Role of fiberoptic bronchoscopy in the diagnosis of pulmonary infiltrates in patients with hematological malignancies. Egypt J Bronchol 12, 340–345 (2018). https://doi.org/10.4103/ejb.ejb_107_17
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejb.ejb_107_17